Delivery Order SPE2DR25D3404-SPE2DR26F5V4A
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Dihydroergotamine 4 mg/mL SpryML, a migraine treatment medication. This firm fixed-price delivery order, valued at $7,776.85, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 through December 2026. The award is non-competitive, reflecting the established...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,757.04 to AmerisourceBergen Drug Corp for the supply of Dihydroergotamine 1 mg/ml ampules. This firm fixed-price delivery order, awarded on December 22, 2025, with an ultimate completion date of December 23, 2025, represents a pediatric migraine treatment pharmaceutical product to be delivered to the place of performance in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation,...
- This is a $2,793.38 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567197504 - Dihydroergotamine 1 mg/ml Ampml, a specialty medication. The contract has a completion date of February 7, 2025 and is a firm fixed price contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,028.06 firm-fixed-price delivery order to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of 4565781870 DIHYDROERGOTAMINE 4 MG/ML SPRYML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of pharmaceutical and medical supplies to...
- This is a $1,775.91 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of dihydroergotamine 1 mg/ml ampules, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,348.94, is for the delivery of dihydroergotamine 1 mg/ml ampules. It is a firm fixed-price delivery order contract with a period of performance through February 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of dihydroergotamine 1 mg/ml ampule, a medication used to treat migraines. The contract has a ceiling value of $3,610.35 and runs through March 13, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DIHYDROERGOTAMINE 1 MG/ML AMPML, a pharmaceutical product. The contract has a firm fixed price of $1,524.90 and a completion date of May 13, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation mentioned. This award is associated with a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of dihydroergotamine 4 mg/ml solution, a specialty medication, with a ceiling value of $4,927.46 and a period of performance through March 2025. The contract is a firm fixed price instrument, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order worth $8,716.00 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIHYDROERGOTAMINE 1 MG/ML AMPML, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
- SPE2DR25D3404Indefinite Delivery Contract
- SPE2DR25D3404-SPE2DR26F5V4ADelivery Order
The Defense Logistics Agency (DLA) awarded a $1,209.04 delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 8, 2026, for the supply of Dihydroergotamine 4 mg/ml SpryML, with a completion date of January 9, 2026. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate headquarters. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), a major pharmaceutical distributor serving federal agencies. This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The contract supports critical medical needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Dihydroergotamine is a vasoconstrictor medication typically used for acute migraine treatment, demonstrating the contractor's role in supplying specialized pharmaceutical products for military personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/7/26 |